Labshake search
Citations for Invivogen :
301 - 350 of 716 citations for Ethyl 5 2 3 difluorophenyl 5 oxovalerate since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2023Quote: Five zebrafish housed in 400-mL beakers containing 200mL sterile tank water were immersed in high molecular weight polyinosine-polycytidylic acid (HMW poly I:C, InvivoGen Cat.# tlrl-pic-5) (50µg/mL final concentration in 200mL tank water ...
-
bioRxiv - Cancer Biology 2022Quote: ... The final product was verified with Sanger sequencing from both directions and incorporated into cells using PEI transfection and selection with G418 (InvivoGen, ant-gn-5).
-
bioRxiv - Developmental Biology 2024Quote: ... The chemical inhibitor or DMSO solution was replaced with fresh solution in the morning of 4 dpf and 5 dpf. Caspase-1 inhibitor - InvitroFit™ Ac-YVAD-cmk (Garcia-Calvo et al. 1998) (InvivoGen inh-yvad) was dissolved in DMSO and used at 20µM final working concentration ...
-
bioRxiv - Cell Biology 2024Quote: ... Isogenic cells stably expressing LEXY from a doxycycline-sensitive promoter were selected by treatment with 200 µg/ml hygromycin B (InvivoGen, ant-hg-5).
-
bioRxiv - Molecular Biology 2024Quote: ... culture of AP2-P-3HA-glmS was transfected at ring stage with 50 μg of pSLI plasmid (containing a blasticidin selection marker) and selected first with 5 μg/mL blasticidin (Invivogen ant-bl-05). Parasites reappeared approximately five weeks after transfection and positive selection for integration was performed via the addition of 400µg/mL G418 (Sigma G8168).
-
bioRxiv - Cell Biology 2024Quote: ... Stable cell lines generated in this background were cultured with 5 µg/ml of blasticidin and 200 µg/ml of hygromycin B (Invivogen #ant-hg-1). To minimise background expression of the transgene ...
-
bioRxiv - Cell Biology 2024Quote: ... diABZI compound 3 (Invivogen, 1µM).
-
bioRxiv - Biophysics 2024Quote: ... 3 μg/ml puromycin (InvivoGen), was exchanged for PBS buffer (DPBS ...
-
bioRxiv - Immunology 2024Quote: ... with diABZI compound 3 (InvivoGen) at 10 µM ...
-
bioRxiv - Immunology 2021Quote: WT and NLRP3-/- iBMDMs were seeded on 150 mm plates at 5×106 cells/plate and on the next day treated with 1 μg/ml LPS (Invivogen, Cat. no: tlrl-b5lps) for 3.5 h. ...
-
bioRxiv - Immunology 2021Quote: ... SARS-CoV-2 S HexaPro protein (1 µg for the first dose and 5 µg for the booster dose) was mixed with 100 µg of aluminium hydroxide (Invivogen, Cat#vac-alu-250). Serum was collected for analysis on study days 14 ...
-
bioRxiv - Cancer Biology 2024Quote: Cells were seeded in a 96-well plate at a density of 5 × 105 cells/mL in 200 μL of medium with 100 ng/mL LPS (InvivoGen, San Diego, CA, USA) and incubated at 37 °C for 24 h ...
-
bioRxiv - Bioengineering 2024Quote: ... Cells were cultured at 37°C with 5% carbon dioxide and were confirmed to be negative for mycoplasma by testing with MycoStrip™ - Mycoplasma Detection Kit (InvivoGen; rep-mys-50) or Myco-Sniff Mycoplasma PCR Detection Kit (MP Biomedicals ...
-
bioRxiv - Immunology 2022Quote: ... 2 ug/mL Pam3CSK4 (TLR1/2 agonist, Invivogen), and 1 ug/mL FSL-1 (TLR2/6 agonist ...
-
bioRxiv - Microbiology 2021Quote: ... and puromycin (3 ug/mL) (InvivoGen). All cell lines were grown at 37°C in 5% CO2.
-
bioRxiv - Immunology 2022Quote: ... and puromycin (3 μg/mL) (InvivoGen). IFNAR KO A549 cells were generated by CRISPR-Cas9 ribonucleoprotein (RNP ...
-
bioRxiv - Biochemistry 2021Quote: ... 3 µg/ml Blasticidin S (InvivoGen) and 0.5 µg/ml Puromycin (Gibco ...
-
bioRxiv - Cell Biology 2023Quote: ... and 3 μg/mL puromycin (Invivogen). For immunoblotting experiments ...
-
bioRxiv - Immunology 2021Quote: ... Cells reconstituted with pLenti CMVie-IRES-BlastR-based constructs were maintained with addition of 5 µg/ml and 1 µg/ml blasticidin (InvivoGen, Cat. no: ant-bl-05) for HEK293T and iBMDMs ...
-
bioRxiv - Immunology 2024Quote: ... at 37°C under 5% CO2 and were routinely tested for mycoplasma contamination using MycoStrip™ detection kit (cat. no. rep-mys, InvivoGen, San Diego, CA, USA).
-
bioRxiv - Bioengineering 2021Quote: ... and 2 µl/ml primicin (Ant-pm-2, InvivoGen) at 37°C for 19 hours.
-
bioRxiv - Bioengineering 2022Quote: ... and 2 μl/ml primocin (Ant-pm-2, InvivoGen) at 37°C for 19 hours ...
-
bioRxiv - Immunology 2022Quote: ... 3 μg/mL puromycin (Invivogen, CA, USA) and 0.1 mg/mL Normocin (Invivogen ...
-
bioRxiv - Immunology 2020Quote: ... a toll-like receptor 3 agonist (InvivoGen). Peptide doses of 50 ...
-
bioRxiv - Cell Biology 2022Quote: ... Selection with Puromicin (3 μg/ml; InvivoGen) started 72 h post infection ...
-
bioRxiv - Immunology 2023Quote: ... 3 hours before infection Pam3CSK4 (Invivogen, tlrl-pms) was spiked into the wells at a final of 100 ng/mL ...
-
bioRxiv - Immunology 2024Quote: ... and 3 μg/mL puromycin (InvivoGen, ant-pr), and 100 μg/mL normocin (InvivoGen ...
-
bioRxiv - Molecular Biology 2021Quote: ... or on solid YPD-agar (1% yeast extract, 2% peptone, 2% D-glucose, 2% agar) and selected with 100 µg/ml Zeocin® (InvivoGen). For small scale expression screening ...
-
bioRxiv - Immunology 2020Quote: ... for 3 days with 0.5 μg/mL LPS (Invivogen) and 0.5 μg/mL anti-IgM F(ab’)2 (Jackson ImmunoResearch) ...
-
bioRxiv - Bioengineering 2022Quote: ... (3) LPS and 150 μg/ml Polymyxin B (Invivogen) for 45 and 90 min ...
-
bioRxiv - Immunology 2022Quote: ... which were selected by blasticidin (3 μg/ml, InvivoGen) for 4 days prior to the experiments.
-
bioRxiv - Cell Biology 2024Quote: ... Pam-3-CSK4 (500 ng/mL, InvivoGen; tlrl-pms), PolyI:C (10 mg/mL ...
-
bioRxiv - Cell Biology 2024Quote: ... 2 months animals were injected intraperitoneally with Pam3CSK4 2 mg/kg (Invivogen tlrl-pms), Pam2CSK4 (0,1 mg/kg ...
-
bioRxiv - Immunology 2022Quote: ... or Alum (Alhydrogel 2%, InvivoGen) at 50% v/v at final volume of 30µl per dose ...
-
bioRxiv - Immunology 2020Quote: ... R848 (2 μg/mL, InvivoGen), CHIKV-LR at a multiplicity of infection (MOI ...
-
bioRxiv - Molecular Biology 2023Quote: ... THP-1 Null 2 (InvivoGen), THP-1 Null 2 NLRP3 KO (InvivoGen ...
-
bioRxiv - Cancer Biology 2022Quote: ... supplemented with 2% Primocin (Invivogen) at 4°C and transported on ice to be processed within 24 hours for organoid culture ...
-
bioRxiv - Biochemistry 2023Quote: ... puromycin (2 µg/ml, InvivoGen), blasticidin (10 µg/ml ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 2% Primocin (Invivogen) at 4°C and transported on ice to be processed within 24 hours for organoid culture ...
-
bioRxiv - Immunology 2024Quote: ... BX795 (InvivoGen, tlrl-bx7-2)
-
bioRxiv - Cell Biology 2024Quote: ... 2 µg/mL puromycin (Invivogen) and 8% heat-inactivated FBS ...
-
bioRxiv - Neuroscience 2023Quote: ... cells were exposed to puromycin (3 μM final concentration, Invivogen) for 5 minutes or left untreated for control conditions ...
-
bioRxiv - Microbiology 2024Quote: ... and 3 µg/ml of Puromycin (Invivogen, #ant-pr-1). ACE2 overexpressing MRC5 cells were cultivated in DMEM supplemented with 20% (v/v ...
-
bioRxiv - Cell Biology 2024Quote: ... Transduced organoids were selected using 3 μg/ml blasticidin (InvivoGen) and maintained as polyclonal populations.
-
bioRxiv - Immunology 2023Quote: Spike proteins (2 μg/dose) were formulated with Alhydrogel 2% (InvivoGen, San Diego, CA, USA) as previously described (20) ...
-
bioRxiv - Cell Biology 2020Quote: ... and doxycycline (Invivogen, 2 mM stock) were dissolved in water.
-
bioRxiv - Microbiology 2020Quote: ... with Primocin (InvivoGen, ant-pm-2), and then digested with Collagenase II (Gibco ...
-
bioRxiv - Bioengineering 2021Quote: ... and Alhydrogel adjuvant 2% (alum, InvivoGen) were used for vaccination studies ...
-
bioRxiv - Genomics 2021Quote: ... and 2 mg/ml puromycin (InvivoGen) were added 24h after infection ...
-
MANF regulates unfolded protein response and neuronal survival through its ER-located receptor IRE1αbioRxiv - Cell Biology 2020Quote: ... and normocin (ant-nr-2, Invivogen). We used the Flp-InTM-CHO to generate CHO-derived stable transgenic cell lines overexpressing either MANF or its mutants from a transcriptionally active locus ...